Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 16 studies | 32% ± 19% | |
luminal cell of prostate epithelium | 4 studies | 18% ± 1% | |
oligodendrocyte | 4 studies | 23% ± 4% |
Insufficient scRNA-seq data for expression of SLC45A3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 37663.46 | 244 / 245 | 100% | 1834.89 | 502 / 502 |
lung | 99% | 760.76 | 572 / 578 | 91% | 12.53 | 1050 / 1155 |
stomach | 91% | 1241.41 | 327 / 359 | 97% | 21.97 | 278 / 286 |
bladder | 86% | 569.43 | 18 / 21 | 88% | 16.23 | 443 / 504 |
esophagus | 82% | 347.05 | 1181 / 1445 | 92% | 17.02 | 168 / 183 |
liver | 100% | 1716.44 | 226 / 226 | 72% | 10.25 | 294 / 406 |
intestine | 77% | 798.97 | 744 / 966 | 94% | 21.33 | 497 / 527 |
ovary | 100% | 673.97 | 180 / 180 | 69% | 6.84 | 296 / 430 |
kidney | 97% | 563.12 | 86 / 89 | 70% | 9.32 | 635 / 901 |
breast | 80% | 436.73 | 365 / 459 | 74% | 8.38 | 829 / 1118 |
brain | 89% | 1106.55 | 2354 / 2642 | 63% | 10.03 | 446 / 705 |
uterus | 95% | 445.72 | 161 / 170 | 58% | 6.87 | 264 / 459 |
skin | 73% | 255.22 | 1326 / 1809 | 59% | 5.95 | 277 / 472 |
pancreas | 28% | 64.23 | 93 / 328 | 95% | 32.86 | 169 / 178 |
adrenal gland | 99% | 847.99 | 255 / 258 | 13% | 1.07 | 30 / 230 |
spleen | 100% | 3530.76 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 48.06 | 1 / 1 |
thymus | 88% | 295.88 | 575 / 653 | 8% | 0.54 | 47 / 605 |
blood vessel | 86% | 568.73 | 1151 / 1335 | 0% | 0 | 0 / 0 |
adipose | 80% | 319.65 | 960 / 1204 | 0% | 0 | 0 / 0 |
heart | 79% | 250.43 | 683 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 66% | 7.33 | 19 / 29 |
muscle | 40% | 168.51 | 319 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 37% | 169.61 | 343 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 27% | 1.95 | 12 / 45 |
eye | 0% | 0 | 0 / 0 | 3% | 0.16 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048713 | Biological process | regulation of oligodendrocyte differentiation |
GO_0008645 | Biological process | hexose transmembrane transport |
GO_0015770 | Biological process | sucrose transport |
GO_0045723 | Biological process | positive regulation of fatty acid biosynthetic process |
GO_0010907 | Biological process | positive regulation of glucose metabolic process |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0008506 | Molecular function | sucrose:proton symporter activity |
GO_0051119 | Molecular function | sugar transmembrane transporter activity |
Gene name | SLC45A3 |
Protein name | Solute carrier family 45 member 3 (Prostate cancer-associated protein 6) (Prostein) |
Synonyms | PRST PCANAP6 |
Description | FUNCTION: Proton-associated sucrose transporter. May be able to transport also glucose and fructose. . |
Accessions | Q96JT2 ENST00000367145.4 |